- Abstract
- Keywords
- Introduction
- Chemistry of BD
- Antineoplastic effects of BD in human malignancies
- Anti-metastatic effects of BD
- Potential anti-inflammatory effects of BD
- Pharmacokinetics, toxicity and metabolism
- Clinical application of BD
- Conclusion and future directions
- Abbreviations
- Declarations
- References
-
Citing Article List
The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer”.No. Publication Date Citing Article 1 2025 Aram A. Musaelyan, Svetlana V. Odintsova, Magaripa A. Urtenova, Ekaterina P. Solovyova, Liliana V. Kindyalova, Sergey V. Orlov. Efficacy of immune checkpoint inhibitors rechallenge and metronomic cyclophosphamide with or without bevacizumab in metastatic nonsmall cell lung cancer, Anti-Cancer Drugs. 2025; https://doi.org/10.1097/CAD.0000000000001723 2 2025 Jing Cheng, Wenwen Kang, Yueying Chen, Luyun Pan, Hedong Han, Tangfeng Lv. Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer, Cancer Immunology, Immunotherapy. 2025; 74: 124. https://doi.org/10.1007/s00262-025-03958-9 -
